These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 22373082)

  • 1. Focal adhesion kinase contributes to proliferative potential of ErbB2 mammary tumour cells but is dispensable for ErbB2 mammary tumour induction in vivo.
    Lahlou H; Sanguin-Gendreau V; Frame MC; Muller WJ
    Breast Cancer Res; 2012 Feb; 14(1):R36. PubMed ID: 22373082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein tyrosine kinase 6 promotes ERBB2-induced mammary gland tumorigenesis in the mouse.
    Peng M; Ball-Kell SM; Tyner AL
    Cell Death Dis; 2015 Aug; 6(8):e1848. PubMed ID: 26247733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mammary gland-specific ablation of focal adhesion kinase reduces the incidence of p53-mediated mammary tumour formation.
    van Miltenburg MH; van Nimwegen MJ; Tijdens I; Lalai R; Kuiper R; Klarenbeek S; Schouten PC; de Vries A; Jonkers J; van de Water B
    Br J Cancer; 2014 May; 110(11):2747-55. PubMed ID: 24809783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mammary epithelial-specific disruption of focal adhesion kinase retards tumor formation and metastasis in a transgenic mouse model of human breast cancer.
    Provenzano PP; Inman DR; Eliceiri KW; Beggs HE; Keely PJ
    Am J Pathol; 2008 Nov; 173(5):1551-65. PubMed ID: 18845837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Focal adhesion kinase-related proline-rich tyrosine kinase 2 and focal adhesion kinase are co-overexpressed in early-stage and invasive ErbB-2-positive breast cancer and cooperate for breast cancer cell tumorigenesis and invasiveness.
    Behmoaram E; Bijian K; Jie S; Xu Y; Darnel A; Bismar TA; Alaoui-Jamali MA
    Am J Pathol; 2008 Nov; 173(5):1540-50. PubMed ID: 18832579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inducible and coupled expression of the polyomavirus middle T antigen and Cre recombinase in transgenic mice: an in vivo model for synthetic viability in mammary tumour progression.
    Rao T; Ranger JJ; Smith HW; Lam SH; Chodosh L; Muller WJ
    Breast Cancer Res; 2014 Jan; 16(1):R11. PubMed ID: 24457046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mammary epithelial-specific disruption of the focal adhesion kinase blocks mammary tumor progression.
    Lahlou H; Sanguin-Gendreau V; Zuo D; Cardiff RD; McLean GW; Frame MC; Muller WJ
    Proc Natl Acad Sci U S A; 2007 Dec; 104(51):20302-7. PubMed ID: 18056629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mammary epithelial-specific ablation of the focal adhesion kinase suppresses mammary tumorigenesis by affecting mammary cancer stem/progenitor cells.
    Luo M; Fan H; Nagy T; Wei H; Wang C; Liu S; Wicha MS; Guan JL
    Cancer Res; 2009 Jan; 69(2):466-74. PubMed ID: 19147559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrin-associated CD151 drives ErbB2-evoked mammary tumor onset and metastasis.
    Deng X; Li Q; Hoff J; Novak M; Yang H; Jin H; Erfani SF; Sharma C; Zhou P; Rabinovitz I; Sonnenberg A; Yi Y; Zhou P; Stipp CS; Kaetzel DM; Hemler ME; Yang XH
    Neoplasia; 2012 Aug; 14(8):678-89. PubMed ID: 22952421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Function of focal adhesion kinase scaffolding to mediate endophilin A2 phosphorylation promotes epithelial-mesenchymal transition and mammary cancer stem cell activities in vivo.
    Fan H; Zhao X; Sun S; Luo M; Guan JL
    J Biol Chem; 2013 Feb; 288(5):3322-33. PubMed ID: 23255596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The receptor tyrosine kinase EphA2 promotes mammary adenocarcinoma tumorigenesis and metastatic progression in mice by amplifying ErbB2 signaling.
    Brantley-Sieders DM; Zhuang G; Hicks D; Fang WB; Hwang Y; Cates JM; Coffman K; Jackson D; Bruckheimer E; Muraoka-Cook RS; Chen J
    J Clin Invest; 2008 Jan; 118(1):64-78. PubMed ID: 18079969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. beta1-integrin is dispensable for the induction of ErbB2 mammary tumors but plays a critical role in the metastatic phase of tumor progression.
    Huck L; Pontier SM; Zuo DM; Muller WJ
    Proc Natl Acad Sci U S A; 2010 Aug; 107(35):15559-64. PubMed ID: 20713705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FAK activates AKT-mTOR signaling to promote the growth and progression of MMTV-Wnt1-driven basal-like mammary tumors.
    Paul R; Luo M; Mo X; Lu J; Yeo SK; Guan JL
    Breast Cancer Res; 2020 Jun; 22(1):59. PubMed ID: 32493400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac fibroblasts require focal adhesion kinase for normal proliferation and migration.
    Manso AM; Kang SM; Plotnikov SV; Thievessen I; Oh J; Beggs HE; Ross RS
    Am J Physiol Heart Circ Physiol; 2009 Mar; 296(3):H627-38. PubMed ID: 19136609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compensatory function of Pyk2 protein in the promotion of focal adhesion kinase (FAK)-null mammary cancer stem cell tumorigenicity and metastatic activity.
    Fan H; Guan JL
    J Biol Chem; 2011 May; 286(21):18573-82. PubMed ID: 21471206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The glucose transporter GLUT1 is required for ErbB2-induced mammary tumorigenesis.
    Wellberg EA; Johnson S; Finlay-Schultz J; Lewis AS; Terrell KL; Sartorius CA; Abel ED; Muller WJ; Anderson SM
    Breast Cancer Res; 2016 Dec; 18(1):131. PubMed ID: 27998284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
    Cabodi S; Tinnirello A; Di Stefano P; Bisarò B; Ambrosino E; Castellano I; Sapino A; Arisio R; Cavallo F; Forni G; Glukhova M; Silengo L; Altruda F; Turco E; Tarone G; Defilippi P
    Cancer Res; 2006 May; 66(9):4672-80. PubMed ID: 16651418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rab11-FIP1C Is a Critical Negative Regulator in ErbB2-Mediated Mammary Tumor Progression.
    Boulay PL; Mitchell L; Turpin J; Huot-Marchand JÉ; Lavoie C; Sanguin-Gendreau V; Jones L; Mitra S; Livingstone JM; Campbell S; Hallett M; Mills GB; Park M; Chodosh L; Strathdee D; Norman JC; Muller WJ
    Cancer Res; 2016 May; 76(9):2662-74. PubMed ID: 26933086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. USP22 overexpression fails to augment tumor formation in MMTV-ERBB2 mice but loss of function impacts MMTV promoter activity.
    Kuang X; Salinger A; Benavides F; Muller WJ; Dent SYR; Koutelou E
    PLoS One; 2024; 19(1):e0290837. PubMed ID: 38236941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Requirement for focal adhesion kinase in the early phase of mammary adenocarcinoma lung metastasis formation.
    van Nimwegen MJ; Verkoeijen S; van Buren L; Burg D; van de Water B
    Cancer Res; 2005 Jun; 65(11):4698-706. PubMed ID: 15930288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.